Opticyte, Inc.

CIK 1718984 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Opticyte, Inc..

Recent SEC filings

FiledFormAccession number
Apr 27, 2026C-AR0001718984-26-000002
Jul 1, 2025C-U0001665160-25-001262
Apr 22, 2025C/A0001665160-25-000738
Apr 22, 2025C-AR0001665160-25-000739
Apr 4, 2025C/A0001665160-25-000519
Feb 12, 2025C/A0001665160-25-000242
Nov 25, 2024C-U0001665160-24-001710
Nov 18, 2024C/A0001665160-24-001639
Oct 31, 2024C0001665160-24-001512
Oct 12, 2017D0001718984-17-000002